ANGIODYNAMICS INC — Director's Dealing 2017

May 25, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2017-04-26

Reporting Person: Campbell Chad Thomas (SVP/GM, Vascular Access)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	13052	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualified Stock Option (right to buy)	$16.59	2023-05-23	Common Stock (85748)		Direct
Performance Right	$		Common Stock (6103)		Direct

Footnotes

F1: This grant of 13,052 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), represents 13,052 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on May 23, 2017, such that 25% of the restricted stock units vested on May 23, 2017 and 25% of the restricted stock units will vest on each of May 23, 2018, 2019 and 2020.

F2: These stock options vest in four equal annual installments beginning on May 23, 2017, such that 25% of the options vested on May 23, 2017 and 25% of the options will vest on each of May 23, 2018, 2019 and 2020.

F3: Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in column 3 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period covering the Company's fiscal years 2017, 2018 and 2019. Any shares that do not vest at the end of the performance period will be forfeited.